
Please try another search
Amazon (NASDAQ:AMZN) is pulling out all stops in its bid to combat the coronavirus crisis. The latest collaboration between its cloud computing arm Amazon Web Services (AWS) and Conduent (NASDAQ:CNDT) , which offers a business process services, is a testament to the same.
Per the deal, Conduent’s Maven has been made available on AWS in a bid to manage the coronavirus pandemic in an efficient way.
Notably, Maven is a disease surveillance and outbreak management platform that helps in automating the integration of reports from patients and test results from labs.
Further, the platform is currently being utilized in the United States to curb the spread of COVID-19 by tracking, managing and reporting the confirmed cases. Further, it engages patients with high exposure to this contagious virus.
At present, tracing of exponentially increasing number of COVID-19 infected people is vital. AWS is striving to cater to this crucial need with the help of Maven whose COVID-19 module aids in reaching out to people who have come into contact with the infected and validating their symptoms digitally.
With this, Amazon aims at helping the public health agencies and organizations to conduct contact tracing seamlessly and accelerate the implementation of their response protocols to restrict the spread of this deadly virus further.
We note that Maven integration remains one of the noteworthy initiatives of Amazon in the community effort to combat the coronavirus pandemic. This is likely to aid the stock in gaining further momentum across investors.
Coming to the price performance, Amazon has returned 10.3% over a year, outperforming the industry’s rally of 2%.
Amazon Ups Initiative in the Pack
Amazon’s latest endeavor provides it a slight edge over other companies including Alphabet (NASDAQ:GOOGL) , Baidu (NASDAQ:BIDU) and Microsoft (NASDAQ:MSFT), which are also taking strong measures to help government and people efficiently manage this pandemic situation.
Notably, Alphabet’s health-care division called Verily has recently launched COVID-19 screening and testing website under Project Baseline. This particular site offers screening and potential free testing of coronavirus. The website requires users to begin with the eligibility questionnaire.
Further, Google recently launched a website in the United States, which offers information related to coronavirus symptoms, treatment and preventive remedies from the World Health Organization.
Meanwhile, Baidu has allowed access to its Linearfold algorithm to the scientific and medical teams for the secondary structure prediction of Covid-19 RNA sequence.
Microsoft has unveiled a COVID-19 tracker tool that offers up-to-date infection statistics of each affected country on the tracker. Moreover, the tool provides access to various coronavirus related articles and other information.
We note that competition is intensifying among the tech companies in managing and preventing the spread of the virus on the back of their robust technologies.
Nevertheless, Amazon’s strengthening initiatives to fight against coronavirus are likely to keep it ahead of the pack.
Currently, Amazon carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
The markets have been sluggish this week as investors hope for a jolt later in the week when AI juggernaut NVIDIA Corporation (NASDAQ:NVDA) reports fourth quarter and year-end...
On Friday, a wave of selling pressure swept across the US equity markets, leaving a trail of losses. The S&P 500 closed down 1.7%, the DOW slid 1.69%, and the NASDAQ tumbled a...
Palantir remains highly valued with a 460x P/E ratio and a 42.5x P/B ratio, far above its peers. The stock's beta of 2.81 signals high volatility, meaning sharp moves in both...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.